Surrozen Inc Sustainability Reports
Surrozen, Inc. is a biotechnology company that discovers and develops drug candidates to selectively modulate the Wnt signaling pathway. The company focuses on promoting tissue regeneration to treat various diseases, including severe liver conditions and retinal disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2021 to 2021
Company Profile
Surrozen, Inc. is a biotechnology company that discovers and develops drug candidates to selectively modulate the Wnt signaling pathway. The company focuses on promoting tissue regeneration to treat various diseases, including severe liver conditions and retinal disorders.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years